A typical hemodialysis needs three sessions per week, for 3-5 hours per session, at a medical facility. Hemodialysis involves pumping a patient’s blood through an external circuit for filtration, before it is pumped back into the body. Hemodialysis is a common type of dialysis for about 90% of all dialysis patients. Peritoneal dialysis utilizes the patient’s own abdomen across which waste is exchanged from the blood and flushed out regularly through a permanent tube in the abdomen. Peritoneal dialysis does not require regular trips to a medical facility; however, it still requires regular treatment at home. Medicare coverage is extended to a person of any age who requires either dialysis or transplantation to maintain life. According to The Regents of the University of California, 750,000 people who live with end-stage renal disease (ESRD) are 1% of the U.S. Medicare population, but account for roughly 7% of the Medicare budget. Hemodialysis care costs the Medicare system an average of $90,000 per patient annually in the U.S., for a total of US$28 billion.
According to National Institute of Diabetes and Digestive and Kidney Diseases, the overall prevalence of chronic kidney disease (CKD) in the general population is approximately 14%. Diabetes and high blood pressure are key causes of CKD. Half the population of individuals having CKD is also combined with cardiovascular disease (CVD) and diabetes. 661,000 people in the U.S. have kidney failure, 468,000 individuals are on dialysis, and 193,000 live with a functioning kidney transplant. Every year, renal disease kills more people than breast or prostate cancer. In 2013, more than 47,000 people in the U.S. died from kidney disease. Estimates are that 2 million people worldwide suffer from ESRD, and the number of patients diagnosed with the disease continues to increase at a rate of 5% to 7% per year. Taiwan, Japan, Mexico, the U.S., and Belgium currently have the highest prevalence of ESRD.
Organ transplant is a cost-effective and life-saving option for patients with organ failure. According to American Medical Association, in the U.S., the supply of organs cannot meet the need of patients on the waiting list, resulting in prolonged morbidity and higher mortality for these patients. Approximately 7500 patients die yearly while awaiting an organ transplant. In the U.S., a suboptimal 54% of adults are registered organ donors, the lack follow up preventing a donation from 20% to 40% of eligible deceased donors.
The global portable dialysis devices market is highly consolidated, owing to the presence of a small number of key players. Leading players operating in the global portable dialysis devices market include:
Global Portable Dialysis Devices Market, by Product
Global Portable Dialysis Devices Market, by End-user
Global Portable Dialysis Devices Market, by Region
Interested in this report?
Get a FREE Brochure now!
*Get Brochure (PDF) sent to your email within minutes
Complete the form below and we'll get back to you shortly.